Featured Research

from universities, journals, and other organizations

Study examines hospital complication rates of bariatric surgery

Date:
July 27, 2010
Source:
JAMA and Archives Journals
Summary:
An examination of hospital complication rates of bariatric surgery for more than 15,000 patients in Michigan finds that the frequency of serious complications is relatively low and is inversely associated with hospital and surgeon procedural volume, according to a new study.

An examination of hospital complication rates of bariatric surgery for more than 15,000 patients in Michigan finds that the frequency of serious complications is relatively low and is inversely associated with hospital and surgeon procedural volume, according to a study in the July 28 issue of JAMA.

With rates of bariatric surgery increasing over the last decade, it has become the second most common abdominal operation in the United States. "Despite trends toward declining mortality rates, payers and patient advocacy groups remain concerned about the safety of bariatric surgery and uneven quality across hospitals," the authors write.

Nancy J. O. Birkmeyer, Ph.D., of the University of Michigan, Ann Arbor, Mich., and colleagues studied perioperative outcomes of bariatric surgery in Michigan, including comparing complication rates by procedure and among hospitals and the relationship between procedure volume, hospital safety, and centers of excellence (COE) accreditation. Standards for COE accreditation vary somewhat between programs, but generally include minimum procedure volume standards, availability of specific protocols and resources for managing morbidly obese patients, and submission of outcomes data to a central registry.

The study involved 25 hospitals, 62 surgeons statewide and data from a clinical outcomes registry. The researchers evaluated short-term morbidity in 15,275 Michigan patients undergoing 1 of 3 common bariatric procedures between 2006 and 2009, and used various analytic tools to assess variation in risk-adjusted complication rates across hospitals and the association with procedure volume and COE designation status.

The researchers found that overall, 7.3 percent of patients experienced 1 or more perioperative complications, most of which were wound problems and other minor complications. Serious complications were most common after gastric bypass (3.6 percent), followed by sleeve gastrectomy (2.2 percent), and laparoscopic adjustable gastric band (0.9 percent) procedures. After adjustment for patient characteristics and procedure mix, rates of serious complications varied from 1.6 percent to 3.5 percent across hospitals. Infection was the most frequent type of surgical site complication (3.2 percent) and was most common among patients undergoing gastric bypass (4.4 percent) and sleeve gastrectomy (2.5 percent) procedures. Fatal complications occurred in 2 patients receiving laparoscopic adjustable gastric band (0.04 percent), 0 patients receiving sleeve gastrectomy, and 13 patients receiving gastric bypass (0.14 percent).

"Risk of serious complications was inversely associated with average annual bariatric procedure volume. For surgeon volume, rates in the low-, medium-, and high-volume categories were 3.8 percent, 2.4 percent, and 1.9 percent, respectively. For hospital volume, adjusted rates of serious complications were 4.1 percent, 2.7 percent, and 2.3 percent in low-, medium-, and high-volume hospitals, respectively. Serious complication rates were about twice as high (4.0 percent) for low-volume surgeons at low-volume hospitals than for high-volume surgeons at high-volume hospitals (1.9 percent)," the authors write. Overall, adjusted rates of serious complications were similar among patients undergoing surgery at COE hospitals (2.7 percent) and among those undergoing surgery at non-COE hospitals (2.0 percent).

The researchers note that the findings of this study may not be generalizable outside of the state of Michigan, but "believe that the results reported in this study represent the outcomes of bariatric surgery that are possible, but not necessarily those that are typical in community settings."

"These data may serve as useful safety performance benchmarks for hospitals performing bariatric surgery. We hope that they might also inform the debate about the effectiveness of various approaches to ensuring high-quality care for bariatric surgery patients."


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Journal Reference:

  1. Nancy J. O. Birkmeyer; Justin B. Dimick; David Share; Abdelkader Hawasli; Wayne J. English; Jeffrey Genaw; Jonathan F. Finks; Arthur M. Carlin; John D. Birkmeyer; for the Michigan Bariatric Surgery Collaborative. Hospital Complication Rates With Bariatric Surgery in Michigan. JAMA, 2010; 304 (4): 435-442 [link]

Cite This Page:

JAMA and Archives Journals. "Study examines hospital complication rates of bariatric surgery." ScienceDaily. ScienceDaily, 27 July 2010. <www.sciencedaily.com/releases/2010/07/100727162904.htm>.
JAMA and Archives Journals. (2010, July 27). Study examines hospital complication rates of bariatric surgery. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2010/07/100727162904.htm
JAMA and Archives Journals. "Study examines hospital complication rates of bariatric surgery." ScienceDaily. www.sciencedaily.com/releases/2010/07/100727162904.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins